Innovative treatments and cures are an integral part of our health care system and can help patients live longer, healthier lives. But vital medicines only work if patients have access. To ensure medical innovation continues to benefit patients, medicines must be both affordable and accessible.
The biopharmaceutical industry is dedicated to finding lifesaving treatments but also making sure patients can access them.
For World Health Day, the World Health Organization reminds us that “everyone, everywhere should be able to access essential, quality health services without facing financial hardship.”
A group of experts recently discussed the ways we can realign the U.S. health care system to improve access and affordability for patients.
In a few weeks, on August 31, the world will recognize International Overdose Awareness Day, which takes place each year and aims to raise awareness of overdose and to reduce the stigma of a drug-related death.
We are on the cusp of a major, positive disruption in the U.S. health care system due in part to the exponential growth in clinical data, advent and incorporation of artificial intelligence and the increasing realignment of the health care sector.